Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Phase one

View:

Post by polo22 on Feb 18, 2022 8:59am

Phase one

Nothing is happening in the last 3 days...
Mr Bailey....do you have any idea why!!!

Comment

Comment by bud13 on Feb 18, 2022 9:42am

this is the 18th right? If the news was there wouldn't it be smart to put it out around the market open?

Comment

Comment by PTBailey on Feb 18, 2022 10:47am

This is from the NR on the Feb. 9, "The Company expects to receive comments or approval from the HREC by February 18th." Note it says "comments or approval" hopefully its approval. Either way they need to come out with something one way or the other. Hopefully more than a comment.

Comment